Most human tumors are characterized by aneuploidy that is believed to be the consequence of chromosomal instability (CIN). The mechanism(s) leading to aneuploidy and the pathways that allow its tolerance are not completely understood. The Spindle Assembly Checkpoint (SAC) is a cellular surveillance mechanism working during mitosis, and alterations of genes that encode components of the SAC weakening the mitotic checkpoint, induce aneuploidy by chromosome mis-segregation. We induced aneuploidy in near-diploid tumor cells by simultaneous depletion of the SAC proteins MAD2 and BUBR1 by RNA interference in the attempt to gain further insight on the cellular responses to aneuploidy. Individual reduction of MAD2 and BUBR1 protein levels caused defective mitosis and aneuploidy, while co-depletion of MAD2 and BUBR1 caused cell cycle arrest and cell death in addition to aneuploidy. The simultaneous reduction of the two SAC proteins induced high percentage of hyperdiploid cells and p53 stabilization suggesting that hyperdiploidy could activate a p53 controlled pathway. The results indicate that p53 is required to induce cell cycle arrest and cell death when the mitotic checkpoint is strongly perturbed, thereby preventing aneuploid cell propagation.
Introduction
Segregation of genetic material into 2 daughter cells during mitosis is a highly regulated event and errors during this phase of the cell cycle can generate cells with aberrant chromosome numbers (aneuploidy). Precise control of progression through mitosis is essential to maintain genomic stability and prevent aneuploidy (Ulrich, in press ). Mutations/alterations in genes encoding mitotic regulators and defects in genes controlling centrosome numbers and tumor suppressors have been suggested as possible causes of aneuploidy (Lentini et al., 2002; Hernando et al., 2004; Fukasawa, 2005; Iovino et al., 2006; Lentini et al., 2006) . Cells have evolved a surveillance mechanism, the Spindle Assembly Checkpoint (SAC), which prevents anaphase onset until all chromosomes are properly attached to the mitotic spindle ensuring that mitosis is faithfully accomplished preserving genome stability. The molecular components of the SAC include Mad1, Mad2, Bubr1, Bub1, Bub3, and Mps1 proteins. Alteration of MAD2 and BUBR1 expression may because of aneuploidy (Guo et al., 2012) . In particular, human colorectal cancer cells (HCT116) and murine primary embryonic fibroblasts (MEFs), in which one MAD2 allele was deleted by homologous recombination, are highly aneuploid (Michel et al., 2001; Lentini et al., 2012) . Haplo-insufficiency of MAD2 also increases the frequency of aneuploid tumors in a p53 background (Amato et al., 2009 ). Intriguingly, aneuploidy and tumorigenesis are also driven by hyperactivation of MAD2 (Sotillo et al., 2007; Schvartzman et al., 2011) . The Bubr1 protein kinase, encoded by the BUB1B gene, is a crucial component for several processes controlling chromosome segregation during mitosis. Genetic mutations of the Bubr1 kinase occur in the cancer susceptible disorder, mosaic variegated aneuploidy (MVA) (Matsuura et al., 2006) , which is a rare disorder characterized by constitutional mosaic aneuploidies associated in most cases with premature chromatid separation (PCS), highlighting the key role of human Bubr1 in chromosome segregation (Matsuura et al., 2006) . Bubr1 also functions in a positive regulatory loop with the tumor suppressor p53, thus enhancing apoptosis of polyploid cells (Shin et al., 2003) . It facilitates phosphorylation and stabilization of p53 after mitotic spindle damage, as well as being a direct p53 transcriptional target (Aylon and Oren, 2011) . Inhibition of Bubr1 in the presence of mitotic poisons accelerates polyploidy in a p53-null background, reinforcing the idea that reduction of chromosome segregation fidelity and acquisition of aneuploid tolerance work synergistically to promote cancer (Shin et al., 2003) . However, the genomic imbalance caused by aneuploidy reduces fitness of euploid cells (Torres et al., 2008) . Similarly, stable near-diploid tumor cells that become aneuploid after treatment with mitotic poisons are removed from the cell population within few generations (Thompson and Compton, 2008) . These findings suggest that cancer cells must acquire the ability to overcome these barriers and that mutations triggering aneuploidy tolerance should accompany chromosome missegregation defects. The mechanisms leading to aneuploid tolerance in tumor cells are not yet completely understood. We found that partial depletion of MAD2 triggered aneuploidy in primary human fibroblasts followed by p53 stabilization that induced premature cellular senescence to avoid the deleterious effects of aneuploidy . p53 could be responsible for the proliferative disadvantage of aneuploidy cells, as suggested also by p53 À/À cells in which aneuploidy remains high. Only a fraction of MAD2 depleted HCT116 cells have whole chromosome aneuploidy associated with p53 activation (Li et al., 2010) . Furthermore, the presence of aneuploid cells in vivo and primary MEFs showing aneuploidy has no proliferative disadvantage, despite having an intact p53 pathway, which suggest that p53 is activated in only some aneuploid cells (Zasadil et al., 2013) . Partial or complete inhibition of the mitotic kinase Aurora B results in chromosome misaggregation or failure of cytokinesis. To limit proliferation of aneuploid cells, a p53-mediated cell cycle arrest is induced, where p53 might be regulated in two separate ways, i.e. by being stabilized by inhibition of Aurora B itself, or by damage to the mitotic spindle apparatus. The stabilization is insufficient to activate p53 and a second pathway, the MAP kinase signaling pathway MAP3K4-p38, is required for transcriptional activation of p53. MAP3K4 might be activated by mitotic spindle disruption and trigger the signal to p38b. Presumably, p38b targets a transcriptional co-factor of p53 leading to full activity of p53 and induction of p21.The cell growth arrest induced by these pathways might prevent chromosomal instability and therefore suppress tumorigenesis (Ulrich, in press ).
We triggered aneuploidy by weakening the SAC after post-transcriptional silencing of MAD2 and BUBR1 genes and investigated whether a p53 controlled pathway is activated in near-diploid tumor cells (HCT116) with a MIN (Microsatellite Instability) phenotype to avoid propagation of highly aneuploidy cells. Individual reduction of Mad2 and Bubr1 protein levels partially affected cell proliferation and caused mitotic spindle defects and aneuploidy in neardiploid HCT116 cells. Conversely, simultaneous Mad2 and Bubr1 depletion resulted in greater effects, leading to cell cycle arrest and high mortality.
Materials and methods

Cells and cell culture
Near-diploid HCT116 and HCT116 p53KO cells (a generous gift of Prof. B. Vogelstein, Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins, Baltimore, MD, USA) with a MIN phenotype were cultured in D-MEM supplemented with 10% FBS (GIBCO, Invitrogen), 100 units/mL penicillin and 0.1 mg/mL streptomycin in a humidified atmosphere of 5% CO 2 in air at 37 C.
RNA interference
For the RNAi experiments, 2 Â 10 5 HCT116 cells were plated in 6-well dishes, incubated at 37 C and transfected 24 h after plating with specific siRNA duplexes. Briefly, the siRNAs and the transfection reagent (Lipofectamine 2000, Invitrogen) were diluted separately in Opti-MEM (Invitrogen) mixed gently, and then incubated for 5 min at RT. After incubation the siRNAs and Lipofectamine 2000 (Invitrogen) were mixed gently, allowed to sit 30 min at RT to allow complex formation and added to the plates for 72 h. After 6 h at 37 C, the transfection medium was replaced with fresh medium. To silence genes of interest, post-transcriptionally, cells were transfected with siRNAs targeting MAD2 (siMAD2: 5 0 -AUACGGACUCACCUUUtt-3 0 ) (Michel et al., 2001) , siRNAs targeting p53 (si p53: 5 0 -GCA UGA ACC GGA GGC CCC AUtt-3 0 ) (Frame et al., 2006) and BUBR1 (siBUBR1: 5 0 -GUCUCACAGAUUGCUGCCUtt-3 0 ) (Choi and Lee, 2008) at 60 nM. The control siRNA (siGFP: 5 0 -GGCUACGUCCAGGAGCGCACCtt-3 0 ) targets the Green-Fluorescent-Protein and was used at 60 nM. All siRNAs (21-nucleotide duplexes) were synthesized by Eurofins-MWG (Germany).
Real time RT-PCR
Primers to be used in Real time RT-PCR experiments were designed with Primer Express software (Applied Biosystems) choosing amplicons of 70-100 bp. The selected sequences were tested on public databases (BLAST) to confirm the identity of the genes. Total RNA was extracted from cells by using the RNAeasy Mini kit (Qiagen). RNA was reverse-transcribed in a final volume of 50 mL using the High Capacity c-DNA Archive kit (Applied Biosystems) for 10 min at 25 C and 2 h at 37 C. For each sample 2 mL of cDNA, corresponding to 100 ng of reverse transcribed RNA, were analyzed by Real time RT-PCR (95 C for 15 s, 60 C for 60 s repeated for 40 cycles), in quadruplicate, using the ABI PRISM 7300 instrument (Applied Biosystems). Real-time RT-PCR was done in 20 mL comprising 1Â Master Mix SYBR Green (Applied Biosystems) and 0.3 mM of forward and reverse primers for: MAD2 (Fwd:
. Data were analyzed by averaging quadruplicates Ct (cycle threshold). Levels of RNA expression were determined by using the SDS software version (Applied Biosystems) according to the 2-DDct method. Levels of RNA expression of selected genes were normalized to the internal control GAPDH.
Western blotting
Protein concentration was measured using the Bio-Rad Protein Assay (Bio-Rad Laboratories). Proteins (50 mg) were separated by 10% SDS-PAGE containing 0.1% SDS and transferred to Hybond-C nitrocellulose membranes (Amersham Life Science) by electroblotting (Lentini et al., 2014) . The membranes were sequentially incubated with p53-DO1 (mouse, 1:1000), p21(mouse, 1:1000), Bubr1 (goat, 1:500), Mad2 (goat, 1:200) as primary antibodies (Santa Cruz,CA), and HRP-conjugated mouse (1:5000), goat (1:5000), and rabbit IgG (1:5000) (Santa Cruz,CA) as secondary antibodies. The target protein was detected with enhanced chemiluminescence Western blotting detection reagents (PIERCE). Membranes were stained with Ponceau-Red to confirm equivalent loading of total protein in all lanes. b-tubulin antibody (mouse; SIGMA-ALDRICH, Italy 1:10.000) was used to confirm proteins loading.
Cell cycle analysis
Asynchronously growing cells were transfected with 60 nM MAD2 siRNA for 72 h before being pulse labeled with 10 mM bromodeoxyuridine (BrdU) for the last 3 h posttransfection. Cells were fixed and stained with anti-BrdU-FITC antibody, to detect S-phase cells, and propidium iodide (PI) to assess the DNA content and analyzed by flow cytometry. Labeling with BrdU allowed monitoring of cells actively engaged in DNA synthesis. DNA content was determined by treating the cells with PBS containing 4 mg/mL of PI and 40 mg/mL RNase. BrdU-labeled cells were analyzed as previously described Lentini et al., 2012) with by FACSCanto (Becton Dickinson). Experiments were repeated at least twice and >10,000 events were analyzed by using the FACSDiva software.
Determination of ploidy
Cells were transfected with the specific siRNA (siGFP, siMAD2, siMAD2/siBUBR1) for 72 h treated with 0.2 mg/mL colcemid (Demecolcine, SIGMA-ALDRICH, Italy) and 1 h, harvested by trypsinization, swollen in 75 mM KCl at 37 C, fixed with 3:1 methanol/acetic acid (v/v), and dropped onto clean, ice-cold glass microscope slides. The slides were airdried and stained with a 3% GIEMSA solution in phosphatebuffered saline for 10 min. Chromosome numbers were counted using a Zeiss Axioskop microscope at a magnification of 100 Â objective.
Trypan blue exclusion test of cell viability
Cells were transfected with the specific siRNAs (siGFP, siMAD2, siBUBR1, siMAD2/siBUBR1) for 72 h, harvested by trypsinization and collected in a tube with 4 mL of phosphatebuffered saline (PBS). Cell suspension (100 mL) were mixed with 100 mL of Trypan Blue (Sigma-Aldrich, Italy) and 10 mL were placed in a Burker chamber for counting.
Immunofluorescence microscopy
To visualize b-tubulin, cells were grown on round glass coverslips and fixed with ethanol/acetic acid 95:5 for 10 min, permeabilized with 0.01% TritonX (Sigma-Aldrich, Italy) in PBS for 15 min and blocked with 0.1% BSA for 30 min at room temperature. Coverslips were incubated with a mouse monoclonal antibody against b-tubulin mouse (SigmaAldrich, Italy, diluted 1:200) overnight at 4 C, followed by a goat anti-mouse IgG-FITC secondary antibody (SIGMA-ALDRICH, Italy, diluted 1:200) for 1 h at 37 C. Nuclei were stained with 1 mg/mL 4 0 ,6-diamidino-2-phenylindole (DAPI) and examined on a Zeiss Axioskop microscope equipped for fluorescence; 200 nuclei for sample were analyzed and images were captured with a CCD digital camera (AxioCam, Zeiss) and printed by Adobe PhotoShop.
Results
Co-depletion of MAD2 and BUBR1 by RNAi reduces cell proliferation
We partially depleted MAD2 and BUBR1 (crucial components of the SAC) by RNA interference in HCT116 cells to investigate if a pathway p53 controlled is activated also in near-diploid tumor cells with a MIN phenotype to avoid propagation of highly aneuploidy cell. Partial reduction of both mitotic proteins was necessary to avoid deleterious effects on cell viability, since their complete depletion can induce death (Michel et al., 2001) . Cells were transfected with specific synthetic siRNAs targeting MAD2 and BUBR1 transcripts (siMAD2, siBUBR1) and unspecific siRNA targeting the green fluorescent protein (siGFP) as a control. siRNAs targeting MAD2, BUBR1 and GFP transcripts were transfected individually or combined (siMAD2/siBUBR1, siMAD2/siGFP). Real-Time RT-PCR analysis showed decreased levels of MAD2 and BUBR1 transcripts in transfected HCT116 cells, demonstrating the efficacy of MAD2 and BUBR1 post-transcriptional silencing by RNAi ( Figure 1A) . In comparison to siGFP cells, siMAD2 and siBUBR1 cells expressed $60% MAD2 and 50% BUBR1 transcripts, respectively ( Figure 1A ).
Western blot analyses confirmed reduction of Mad2 and Bubr1 protein levels in siMAD2 and siBUBR1 cells in comparison to siGFP cells ( Figure 1B) . At 72 h, posttranscriptional silencing of MAD2, there was a fourfold increase of BUBR1 mRNA and protein expression levels ( Figure 1A-B) . After BUBR1 posttranscriptional silencing MAD2 expression was reduced ( Figure 1A-B) , possibly due to the slowdown of the cell proliferation.
Early effects (72 h post-transfection) of MAD2 and BUBR1 partial post-transcriptional silencing resulted in slowing down of the cell proliferation of HCT-siMAD2 and HCT-siBUBR1 cells, as indicated by estimation of the cellular density/dish that was lower than the one of siGFP cells ( Figure 1C, D) . Reduction of proliferation was specific for cells transfected with siRNAs targeting MAD2 and BUBR1. In contrast, transfection with unspecific siRNA (siGFP) did not affect cell proliferation (Figure 1C, D) . Trypan blue staining showed that double silenced HCTsiMAD2/siBUBR1 cells had higher mortality (about 80%) in comparison to HCT-siMAD2 (40%), HCT-siBUBR1 (50%), and the double silenced HCT-siMAD2/siGFP cells (40%).
Depletion of MAD2 and BUBR1 induces aneuploid cells and mitotic spindle alterations
To estimate the number of aneuploid cells after MAD2, BUBR1, and MAD2/BUBR1 post-transcriptional silencing, cells were treated with colcemid. The great majority of HCT-siMAD2 and HCT-siBUBR1 aneuploid cells (Figure 2A -B) were hypodiploid (85 and 82%, respectively) and the less extent of hyperdiploids (10 and 3%, respectively), whereas co-depleted HCT-siMAD2/ siBUBR1 cells had 18% hyperdiploid cells, 52% hypodiploid cells, and 30% euploid cells (Figure 2A-B) . Immunofluorescence microscopy analyses by b-tubulin staining of HCT-siGFP, HCT-siMAD2, HCT-siBUBR1, and HCT-siMAD2/siBUBR1 indicated cells with mitotic spindle alterations as associated with incorrect distribution of chromosomes ( Figure 2C and Figure S1 ). Various mitotic spindle defects after MAD2, BUBR1, and MAD2/ BUBR1 post-transcriptional silencing were seen. In particular, monopolar spindles in 14% siMAD2, 12% siBUBR1, and 12% of siMAD2/siBUBR1 depleted cells, disorganized chromosomes in the spindle in 46% siMAD2, 48% siBUBR1, and 56% of siMAD2/siBUBR1 silenced cells, respectively ( Figure S1 ). In contrast, only 10% of HCT-siGFP cells showed alterations of mitotic spindle, which suggests that depletion of Mad2 and Bubr1 proteins individually or combined induced alterations of both chromosomes and the mitotic spindle.
MAD2 and BUBR1 co-depleted cells undergo p53-dependent cells cycle arrest
The slowing down of proliferation after MAD2, BUBR1 and MAD2/BUBR1 post-transcriptional silencing ( Figure 1C-D) suggests that part of these cells arrested or proceeded more slowly in the cell cycle. We therefore assessed by bivariate (PI and BrdU) FACScan (cytofluorimetric) analyses whether MAD2, BUBR1 and MAD2/BUBR1 post-transcriptional silencing was associated to different cell cycle profiles in HCT116 cells. Cells transfected with siRNA duplexes targeting MAD2, BUBR1, MAD2/BUBR1, and GFP were analyzed after 72 h from transfection and BrdU was added for 1 h to assess their ability to enter S-phase ( Figure 3A) . FACScan analyses was conducted only on adherent cells and showed that HCT-siMAD2 and HCT-siBUBR1 accumulated in G1 (82 and 86%, respectively) and G2/M (10 and 6%, respectively); only 8% of these cells were in S-phase (BrdU positive). In contrast, 14% of the HCT-siGFP control cells entered S-phase. As expected, only a minor fraction of HCTsiMAD2/siBUBR1 cells were in S-phase (BrdU positive: 0.9%) whereas all the remaining cells arrested in G1/S (87%) and G2/M (12.1%) ( Figure 4A ). Early effects of siMAD2/siBUBR1 post-trascriptional silencing on cell proliferation in HCT116 cells could be the result of the activation of a cellular G1/S checkpoint. Thus expression of the principal genes involved in G1/S checkpoint were investigated by Real-Time PCR and Western blot analysis. Increased levels of p21 waf1 transcript and protein in siMAD2/siBUBR1-HCT cells were seen ( Figure 3B-D) . The increased level of p21 waf1 that may have been induced by p53 seem to be stabilized, as indicated by its protein level (Figure 3C, D) . To understand whether the p53 and p21 waf1 axis was responsible for the observed cell cycle arrest in siMAD2/siBUBR1-HCT cells, RNAi MAD2 and BUBR1 genes in combination with the p53 gene were silenced, and reduction of the MAD2, BUBR1, and p53 transcripts and protein assessed by RT-PCR and western blotting ( Figure 4A, B) . Flow cytometry showed that siMAD2/siBUBR1/siP53-HCT cells could re-enter in the cell cycle after 72 h from siRNAs transfection ( Figure 4C ). siMAD2/siBUBR1/sip53-HCT cells also had a greater proliferative capacity than siMAD2/siBUBR1-HCT cells ( Figure 4D ). However, there was no reduction of p21 waf1 mRNA and protein levels after p53 depletion ( Figure 4A, B) . Similar results were obtained in cells null for p53; in fact transfected MAD2/BUBR1 siRNAs in HCT-p53KO cells proliferated better than HCT-siMAD2/BUBR1 cells after 72 h of transfection ( Figure S2A-B) . The findings suggest that HCT116 cells activate a p53-dependent cell cycle arrest and death (p21 waf1 independent) to prevent aneuploid cells propagation caused by depletion of MAD2 and BUBR1.
Discussion
Epidemiological and genetic analyses have led to an estimation of about six mutations being needed for malignant transformation on the somatic mutation theory of cancer (Vogelstein, 1996) . Given the mutation rate in humans, it is extremely rare for a single cell to acquire all the necessary mutations. Thus, it has been postulated that destabilizing the genome is necessary for cancer development. A prominent form of genetic instability in cancer is chromosomal instability (CIN) that results in gains or losses of whole chromosomes or translocation of chromosome segments. Alterations in chromosome number (aneuploidy) are found in nearly all tumor types of human origin. Aneuploidy would represent an epiphenomenon of cancer pathogenesis, a by-product of the hypermutable state exploited by tumor cells during the process of tumor progression to accumulate the mutant alleles essential for malignant proliferation (Zimonjic et al., 2001) . However, no specific advantages can be associated with a particular gain or loss of a chromosome most of the time. Previously, we showed that is not sufficient to induce chromosomal instability in colon cancer cells with a MIN phenotype by destabilizing the mitotic spindle (for example by centrosome amplification); it has to be associated with alterations in genes regulating mitosis progression, such as Aurora-A/STK15 to trigger CIN (Lentini et al., 2007) .
Cancer cells can have gross abnormalities in their chromosome numbers, most as a result of defects in the quality control of sister chromatid separation (Weaver et al., 2007) . Thus, a complete lack of SAC function does not cause cell lethality per se; rather, the cells are eliminated by other protecting mechanisms. Enhanced proteasomal degradation has been suggested as one aneuploidy tolerating mechanisms (Torres et al., 2010) . Also, dysfunction of the p38-P53 axis has been suggested as promoting proliferation of aneuploid human tumor cells (Burds et al., 2005) . It was also suggested that heightened energy metabolism in aneuploid cells may be behind the surge in ROS levels. Increased ROS cause DNA damage that activates the ATM/P53 pathway, and this depends on the severity of aneuploidy (Li et al., 2010) .
Simultaneous reduction of MAD2 and BUBR1 gene expression compromises cell viability and are consistent with previous observations showing that the simultaneous depletion of SAC genes could be exploited as a possible strategy to kill cancer cells (Burds et al., 2005) . Furthermore, we suggest the weakening of the SAC checkpoint caused by MAD2 and BUBR1 reduction increased chromosome segregation errors, which in turn induced aneuploidy followed by arrest of cell proliferation and death associated with p53 stabilization. Following MAD2 transcript reduction there was a strong increase of the BUBR1 mRNA and protein expression levels. This is consistent with what already reported (Shin et al., 2003; Kops et al., 2004) and it could be correlated with a response to the aneuploidy (hyperdidploidy) induced by MAD2 depletion (Baker et al., 2013) . Thus, BUBR1 seems to have an important role against aneuploid cells formation/propagation and its increase could be necessary to eliminate hyperdiploid cells from the population. The simultaneous reduction of the 2 SAC proteins induced high percentage of hyperdiploid cells and p53 stabilization, suggesting that hyperdiploidy could activate a p53 controlled pathway accordingly to published reports (Thompson and Compton DA:, 2010; Stuabach, in press ). On the contrary, aneuploid cells generated by single silencing of MAD2 or BUBR1 did not show high levels of hyperdiploidy and did not activate the p53-controlled checkpoint. This conclusion is supported by p53 post-transcriptional silencing by siRNA in MAD2 and BUBR1 co-depleted cells allowing cells to re-enter the cell cycle. This was also seen in cells null for p53 (HCT-p53KO), when MAD2 and BUBR1 were simultaneously silenced. After p53 depletion by RNAi, we unexpectedly did not find a decrease of p21 waf1 protein levels, which suggests that p21 waf1 is only partially involved in the arrest of the cell cycle observed in HCT116-MAD2/BUBR1 cells and that its increase in aneuploidy cells is not only under the p53 control.
In conclusion, our results indicate that MAD2 and BUBR1 reduction causes mitotic spindle dis-organization and incorrect distribution of chromosomes along the spindle in the absence of mitotic poisons, and, importantly, that a p53-controlled pathway is required to induce cell cycle arrest or cell death to avoid aneuploid cells proliferation. 
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